OcuSciences, Inc. announced at ARVO that the FDA has granted marketing clearance for its flagship device, the OcuMet Beacon, a confocal scanning ophthalmoscope designed for infrared and autofluorescence imaging of the retina.
These types of improvements are relatively common after initial approval and are the result of optimization as surgical techniques and knowledge evolve.
Conexiant
May 01, 2025
Discover the latest advancements and best practices in retina specialties at the global Retina World Congress.
Retinal Physician
May 01, 2025
Discover insights and innovations in retinal care at the esteemed Retina World Congress.
Retinal Physician
May 01, 2025
Discover the latest in retinal health at the annual Retina World Congress, where top specialists and industry leaders converge to share insights and innovations.
Retinal Physician
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
May 01, 2025
Join the Retina World Congress with leading specialists and industry experts to explore the forefront of retinal disease research and treatment.
Retinal Physician
May 01, 2025
Explore the latest breakthroughs in retinal disease research and treatment at the global Retina World Congress.
Retinal Physician
May 01, 2025
Explore the latest advancements and best practices in diagnosing and treating retinal diseases and disorders at the Retina World Congress, where leading experts collaborate to drive innovation in patient care.
Higher genetic risk for schizophrenia correlated with reduced macular thickness, but the “variation is very unlikely to have an impact on visual acuity.”